| ¿µ¹® | upper GI series | ÇÑ±Û | »óºÎÀ§Àå°üÁ¶¿µ¼ú |
|---|---|---|---|
| ¼³¸í | X-¼± »çÁø¿¡¼ Àß ³ªÅ¸³ª´Â Á¶¿µÁ¦(¹æ»ç¼±ÃÔ¿µ»ó¿¡¼ ÇϾé°Ô ³ªÅ¸³ª ÁÖÀ§Á¶Á÷°ú °¨º°ÀÌ ¿ëÀÌÇÏ´Ù)¸¦ ¼·ÃëÇÑ ÈÄ ½Äµµ, À§, »ùâÀÚ, ÀÛÀºÃ¢ÀÚ»óºÎ±îÁö X-¼± ÃÔ¿µÇϹǷνá, ±×°÷ ¼ÒȰü³»ÀÇ ÀÌ»óº´ÅÍ¿©ºÎ¸¦ °Ë»çÇÏ´Â °Í. Á¶¿µÁ¦´Â ÁÖ·Î ¹Ù·ýÀ» »ç¿ëÇÏ¸ç ´õ ¼±¸íÇÑ ¿µ»óÀ» ¾ò±âÀ§ÇØ ¹ßÆ÷Á¦¸¦ ÇÔ²² ¼·ÃëÇÏ¿© ¹Ù·ý°ú °ø±âÀÇ ÀÌÁßÁ¶¿µÃÔ¿µÀ» Çϱ⵵ ÇÑ´Ù. ½Äµµ¾Ï, À§¾Ï ¹× ¼Òȼº±Ë¾ç°ú ±×¹Û¿¡ ´Ù¾çÇÑ º´º¯ÀÇ Áø´Ü¿¡ È¿°úÀûÀ¸·Î »ç¿ëµÈ´Ù. |
||
| ¿µ¹® | small bowel series | ÇÑ±Û | ÀÛÀºÃ¢ÀÚ Á¶¿µ¼ú, ¼ÒÀå Á¶¿µ¼ú |
|---|---|---|---|
| ¼³¸í | ¹æ»ç¼± Á¶¿µÁ¦(¹æ»ç¼±°Ë»ç¿¡¼ ´Ù¸¥ ºÎÀ§¿Í ´ëÁ¶µÇ´Â ¾ÆÁÖ Èò»öÀ» ¶ì´Â ¹°Áú)ÀÎ ¹Ù·ýÀ» ¼·ÃëÇÑ µÚ, ÃÔ¿µÇÏ´Â ÀÛÀºÃ¢ÀÚÀÇ ±âº»ÀûÀÎ ¹æ»ç¼± °Ë»ç·Î¼, ¹æ¹ýÀº 200~300mLÀÇ ¹Ù·ýÀ» ¸ÔÀºµÚ ¹Ù·ýÀÌ ÀÛÀº âÀÚ¸¦ Åë°úÇÏ´Â µ¿¾È Á¤±ÔÀû °£°ÝÀ¸·Î ¹æ»ç¼± »çÁøÀ» ÂïÀ½. ÀϹÝÀûÀ¸·Î 2~3½Ã°£ÀÌ °É¸². |
||
| PIE | 1) Post-Infectious Encephalomyelitis 2) Pulmonary Interstitial Emphysema;... |
|---|---|
| UGIS | Upper Gastro-Intestinal Series |
| CFU-EOS, | CFUEOS colony-forming unit, eosinophil |
| ECP | ectrodactyly-cleft palate [syndrome]; effector cell precursor; endocardial potential; eosinophil cat... |
| EDF | eosinophil differentiation factor; erythroid differentiation factor; extradural fluid |
| SEC | Series elastic component |
|---|---|
| EO | Eosinophil |
| ECP | Eosinophil Cationic Protein |
| ECA | Eosinophil chemotactic activity |
| ECF | Eosinophil chemotactic factor |
seriflux
| absolute eosinophil count | <haematology, investigation> A measurement (cells per microlitre) of the number of eosinophils in a blood specimen. This measurement is useful in the evaluation of autoimmune disease, allergies, eczema, leukaemia, asthma and hay fever. Normal absolute eosinophil counts are less than 350 cells/mcl (microlitre). (27 Sep 1997) |
|---|---|
| chemotactic factors, eosinophil | Cytotaxins liberated from normal or invading cells that specifically attract eosinophils; they may be complement fragments, lymphokines, neutrophil products, histamine or other; the best known is the tetrapeptide ecf-a, released mainly by mast cells. (12 Dec 1998) |
| eosinophil | Polymorphonuclear leucocyte (granulocyte) of the myeloid series, of which the granules stain red with eosin. Phagocytic, particularly associated with helminth infections and with hypersensitivity. (18 Nov 1997) |
| eosinophil adenoma | <endocrinology, oncology, tumour> A benign tumour, usually found in the anterior lobe of the pituitary gland, whose cells stain with acid dyes. Such pituitary tumours may give rise to excessive secretion of growth hormone, resulting in gigantism or acromegaly. A specific type of acidophil adenoma may give rise to nonpuerperal galactorrhoea. (25 Jun 1999) |
| eosinophil cationic protein | <protein> Arginine rich protein (21 kD) in granules of eosinophils, that damages schistosomula in vitro. Not the same as the MBP (major basic protein) of the granules. (18 Nov 1997) |
| eosinophil chemotactic factor of anaphylaxis | A peptide (MW 500 to 600) that is chemotactic for eosinophilic leukocytes and is released from disrupted mast cells. (05 Mar 2000) |
| eosinophil chemotactic peptide | <protein> Tetrapeptides (of which two are identified: VGSE and AGSE) released by mast cells and that are said to both attract and activate eosinophils. (18 Nov 1997) |
| eosinophil count | A measurement (cells per microlitre) of the number of eosinophils in a blood specimen. This measurement, also called the absolute eosinophil count, is useful in the evaluation of autoimmune disease, allergies, eczema, leukaemia, asthma and hay fever. Normal absolute eosinophil counts are less than 350 cells/mcl (microlitre). (27 Sep 1997) |
| eosinophil granule | A granule that stains with eosin. (05 Mar 2000) |
| eosinophil peroxidase | <enzyme> Peroxidase from eosinophil granules distinct from myeloperoxidase; claimed to enhance destruction of fungi, bacteria, schistosomula, toxoplasma, trypanosoma, mast cells, tumour cells in presence of exogenous h2o2 and halide Registry number: EC 1.11.1.- (26 Jun 1999) |
| aromatic series | All the compounds derived from benzene, or similar cyclic compounds that obey Huckel's rule, distinguished from those compounds that are acyclic or that contain rings that lack the conjugated double bond structure characteristic of benzene. (05 Mar 2000) |
| granulocytic series | <haematology> The cells in the several stages of development in the bone marrow leading to the mature granulocyte of the circulation, e.g., myeloblasts, different stages of the myelocyte, granulocytes. (05 Mar 2000) |
| myeloid series | The granulocytic and the erythrocytic series. (05 Mar 2000) |
| Hofmeister series | <chemistry> The series of cations Magnesium, Calcium, Sr2+, Ba2+, Li+, Na+, K+, Rb+, Cs+, and of anions citrate3-, tartrate2-, SO42-, acetate-, NO3-, CIO3-, I-, CNS- (among others). Each series is arranged in order of decreasing ability to: 1) precipitate the dispersed substance of lyophilic soltions; 2) "salt out" organic substances (e.g., aniline, ethyl acetate) from aqueous solutions; or 3) inhibit the swelling of gels. These effects, among other related ones, are ascribable to the abstraction and binding of water by these ions (i.e., hydration), which also decreases in the orders given, so that (in the monovalent cation series) Li+, with the smallest crystal radius, has the largest hydrated radius, and vice versa for Cs+. Synonym: lyotropic series. (05 Mar 2000) |
| homologous series | A series of organic compounds, the succeeding members of which differ from each other by the radical CH2 (as in the fatty series). (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|